Much of human cancer is a product of aging, from errors during DNA replication, environmental exposures, and the inevitable failure of our bodies. What causes cancer in young people and…
Read More
Functional Cancer Proteomics We are a group of biochemists, biologists and physicians in the Molecular Pharmacology Program at the Sloan Kettering Institute in New York City, USA. We carry out…
Read MoreDiscovery of biomarkers for improved precision in oncology remains a critical problem. This is particularly pressing for cancers that currently lack adequate markers for stratification of chemotherapy and targets for…
Read MoreSo excited to share our publication today! Working with the awesome @markwbudde, A. Granados, and other brilliant minds in the @ElowitzLab, Lois Lab, and @LongCai_Lab, we developed a synthetic recording system to image single cell lineage history. https://science.sciencemag.org/content/372/6538/eabb3099
Excited to share our latest work published today: Silencing of LINE-1 Retrotransposons is a Selective Dependency of Myeloid Leukemia
https://www.nature.com/articles/s41588-021-00829-8
@CRI_UTSW @UTSWNews @NatureGenet
Delighted that our new paper on the role of extrachromosomal DNA elements as mobile enhancers is online. Wonderful collaboration with the lab of Chia-Lin Wei. https://www.cell.com/cancer-cell/fulltext/S1535-6108(21)00164-1
Dr. Scott Keeney (@Spo11Rulz) has been studying a protein called Spo11 for two decades. But it wasn't until a postdoc in Dr. Keeney's lab, @ccb_Lab, came along that they were able to answer key questions about Spo11's role in #meiosis. https://bit.ly/3t3VNNY
Sharing this piece about my friend and colleague Buzz Baldwin who passed away last month. https://med.stanford.edu/news/all-news/2021/03/Robert-Baldwin-biochemistry-department-dies-at-93.html Buzz was a pioneer in biochemistry and a wonderful, caring person. We are all missing him @StanfordBiochem.
